Bionano Genomics (BNGO) Shares Outstanding (Weighted Average) (2017 - 2026)

Bionano Genomics' Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $12.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 348.42% year-over-year to $12.1 million; the TTM figure through Mar 2026 stood at $12.1 million (up 348.42% YoY), while the FY2025 annual figure was $5.4 million, up 328.4% from the prior year.
• Shares Outstanding (Weighted Average) came in at $12.1 million for Q1 2026 at Bionano Genomics, roughly flat from $12.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $65.5 million in Q3 2024 to a low of $8000.0 in Q4 2022.
• A 5-year average of $11.4 million and a median of $4.4 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) plunged 99.86% in 2023 and surged 163540.0% in 2024, its largest moves.
• Bionano Genomics' Shares Outstanding (Weighted Average) stood at $8000.0 in 2022, then soared by 4425.0% to $362000.0 in 2023, then surged by 251.1% to $1.3 million in 2024, then jumped by 850.47% to $12.1 million in 2025, then changed by 0.0% to $12.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $12.1 million, $12.1 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison